Imcyse

Imcyse

Foundation date

10/08/2010

Sector

#Biotechnology - Therapeutics

Subsector

• #Therapeutics - Cell therapy
• #Therapeutics - Vaccines

Therapeutic areas

• #Diseases of the blood and blood-forming organs - immune disorders
• #Infectious and parasitic diseases

Imcyse develops active targeted immune therapies (ImotopesÔ) that locally inhibit the immune cells involved in the destruction of the diseased organ. The targeted approach and memory effect of the Imcyse technology help to prevent and cure diseases with no current therapeutic alternative, caused by disruptions of the immune system without impairing the patient’s immune defences.